Sign in
4

Changes in Ownership

Dare Bioscience, Inc. Filed Acc 0001209191-16-138301

Options or other derivatives

  • SVP, Chief Medical Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Senderowicz Adrian SVP, Chief Medical Officer 2016-08-22 Grant or award · Stock Option (right to buy) +100,000 100,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…